Senior insider sale
Principal Accounting Officer at MONTE ROSA THERAPEUTICS, INC. — senior position signals high conviction
$483.1K
26.88K shares
What this filing means
DUNN EDMUND plans to sell 26.88K shares of MONTE ROSA THERAPEUTICS, INC. valued at approximately $483.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/4/2026ACC: 0001193125-26-091704
Officer· Principal Accounting Officer
Since Mar 2026
26.88K
Shares to sell
$483.1K
Approx. market value
139.00
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
RSU Vest
Equity Compensation
3/3/2026
139.00Total acquired139.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/3/2026 | RSU Vest Equity Compensation | 139.00 | — |
| Total | 139.00 | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
536.00
Market value
$9.4K
3/2/2026
—Completed
Units to sell
25.16K
Market value
$455.5K
2/27/2026
—Completed
Units to sell
1.04K
Market value
$15.8K
1/5/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
139.00
Market value
$2.5K
3/4/2026
Total
Units
26.88K
Value
$483.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/2/2026 | 536.00 | $9.4K | — | Completed |
2/27/2026 | 25.16K | $455.5K | — | Completed |
1/5/2026 | 1.04K | $15.8K | — | Completed |
| Planned — Approximate Date | ||||
3/4/2026 | 139.00 | $2.5K | NASDAQ | Planned |
| Total | 26.88K | $483.1K | ||